RAVELLI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 187
EU - Europa 137
AS - Asia 100
SA - Sud America 15
Totale 439
Nazione #
US - Stati Uniti d'America 185
CN - Cina 40
IT - Italia 36
SG - Singapore 36
IE - Irlanda 34
SE - Svezia 16
BR - Brasile 14
DE - Germania 13
HK - Hong Kong 10
CZ - Repubblica Ceca 7
AT - Austria 6
NL - Olanda 6
BE - Belgio 4
FI - Finlandia 4
FR - Francia 4
TR - Turchia 4
RU - Federazione Russa 3
GB - Regno Unito 2
JP - Giappone 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
CO - Colombia 1
GT - Guatemala 1
ID - Indonesia 1
IN - India 1
IQ - Iraq 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
PL - Polonia 1
UA - Ucraina 1
Totale 439
Città #
Dublin 34
Chandler 31
Singapore 22
Parma 20
Santa Clara 17
Dearborn 13
Ann Arbor 11
Hong Kong 10
New York 10
Ashburn 7
Nanjing 7
Shanghai 7
Boardman 6
Brno 6
Munich 6
Shenyang 6
Princeton 5
Vienna 5
Brussels 4
Izmir 4
Redmond 4
Bremen 3
Norwalk 3
San Mateo 3
Beijing 2
Columbus 2
Fuzhou 2
Hebei 2
Hefei 2
Helsinki 2
Los Angeles 2
Moscow 2
Seattle 2
Tashkent 2
Wilmington 2
Woodbridge 2
Abreu e Lima 1
Bacoli 1
Baghdad 1
Betim 1
Bragança Paulista 1
Brooklyn 1
Buffalo 1
Cagliari 1
Camocim 1
Caraguatatuba 1
Changsha 1
Chicago 1
Cotiporã 1
Dallas 1
Dubai 1
Frankfurt am Main 1
Fremont 1
Guangzhou 1
Guatemala City 1
Houston 1
Huizen 1
Indaiatuba 1
Itacoatiara 1
Jakarta 1
Jinan 1
Kunming 1
London 1
Medellín 1
Mumbai 1
Nanchang 1
Redwood City 1
Rio de Janeiro 1
Sabará 1
Saint Petersburg 1
Santa Albertina 1
Santo André 1
Scottsdale 1
Seoul 1
São João da Boa Vista 1
Taizhou 1
Tianjin 1
Torino 1
Turku 1
Vancouver 1
Viamão 1
Vientiane 1
Wake Forest 1
Warsaw 1
Wenzhou 1
Totale 317
Nome #
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 115
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 96
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility 92
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells 85
CDK4/6 inhibitors in HER2-positive breast cancer 73
Totale 461
Categoria #
all - tutte 1.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 5 1 0 1 0 2 3 0
2021/202219 0 0 0 1 0 0 5 2 0 2 0 9
2022/2023125 10 15 10 10 7 13 0 7 42 0 9 2
2023/202452 4 3 1 1 5 14 5 0 1 3 4 11
2024/2025121 1 5 7 10 18 14 7 2 21 6 13 17
Totale 461